Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 9Recruiting 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Uveal Melanoma 1Recurrence 1Neoplasm, Residual 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Melanoma 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Hodgkin Disease 1Hematologic Neoplasms 1Graft vs Host Disease 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Azacitidine 10Decitabine 9Cyclophosphamide 9Cytarabine 7Tacrolimus 6Antilymphocyte Serum 6fludarabine phosphate 5Mycophenolic Acid 5Melphalan 5Busulfan 5fludarabine 4Whole-Body Irradiation 4Peripheral Blood Stem Cell Transplantation 4Idarubicin 4Rituximab 3Polymerase Chain Reaction 3Lenalidomide 3Filgrastim 3venetoclax 2sargramostim 2Tretinoin 2Radiotherapy 2Methylprednisolone 2Methotrexate 2Flow Cytometry 2Etoposide 2Cyclosporine 2Cord Blood Stem Cell Transplantation 2Clofarabine 2Blood Specimen Collection 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Myelodysplastic Syndromes × treosulfan × Clear all
NCT01894477 2021-06-03

Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Fred Hutchinson Cancer Center

Phase 2 Unknown
102 enrolled 12 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Neoplasm, Residual, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡